摘要
为探讨罗哌卡因复合舒芬太尼蛛网膜下腔阻滞用于肛肠疾病手术的价值,将2016年7月至2018年4月于我院择期接受手术治疗的78例肛肠疾病患者随机分为观察组和对照组,各39例,对照组采用罗哌卡因蛛网膜下腔阻滞,观察组采用罗哌卡因复合舒芬太尼蛛网膜下腔阻滞,对比2组麻醉效果及不良反应。结果显示,2组肛门松弛优良率、牵拉反应阳性率及Bormage运动评分比较,差异均无统计学意义,P>0.05;观察组感觉阻滞时间短于对照组,不良反应发生率高于对照组,差异有统计学意义,P <0.05。结果表明,肛肠疾病手术单纯应用罗哌卡因进行蛛网膜下腔阻滞即可,复合舒芬太尼并未增强麻醉效果,反而不良反应增加,因此,无需复合舒芬太尼。
This study was to estimate the value of the compound anesthesia of Ropivacaine and Sufentanil applied in subarachnoid block during colorectal disease(CD)surgery,randomly divided 78 CD patients to be subject to surgery in author’s hosptial(2016-07-2018-04)into control group(39 cases,alone Ropivacaine for subarachnoid block)and observation group(39 cases,compound Ropivacaine and Sufentanil for subarachnoid block),then compared both’s efficacy of anesthesia and untoward reaction status.As results,in the excellent rate of anus relaxation,in the positivity rate of tractive reaction,and Bormage movement score there was no statistical difference between the two groups(P>0.05);in the time for sensation blocked,and in the incidence of untoward reactions,observation group was significantly shorter and higher than control group,there were statistical difference between them(P<0.05).Results show that it is not necessary to compound Sufentanil with Ropiracaine because alone Ropivacaine for subarachnoid block is enough for achieving anesthesia efficacy,compound Sufentanil does not increase the efficacy,instead increase untoward reaction,so is needed.
作者
王家轩
WANG Jia-xuan(Dept.of Anesthesia,the Peopel's Hospital of Nanzhao County,Nanyang,Henan 473000)
出处
《中国肛肠病杂志》
2019年第5期42-43,共2页
Chinese Journal of Coloproctology
